Skip to content

Press Release

Altron suspends executives at subsidiary Altron Nexus over allegations of irregularities

Three senior executives of Altron Nexus, a subsidiary of JSE-listed technology company Altron, have been placed on precautionary suspension following an investigation that has revealed potential internal irregularities.

After receiving information from a whistle-blower in June 2018, Altron appointed independent investigators to look into alleged procurement irregularities among a few senior executives within Altron Nexus. The investigation found no evidence of irregularities but made recommendations on procurement process improvements and reporting obligations, which were implemented.

In June this year Altron received a second tip-off from a whistle-blower on similar allegations. The company immediately initiated another investigation conducted by forensic services company, Naledi Advisory Services.

The preliminary findings have revealed potential deviation from procurement processes, involving an estimated R23 million, and early profit recognition of approximately R20 million in the 2018 financial year.

“We view these allegations in a serious light. Accordingly, this investigation is in line with our zero-tolerance to unethical conduct, despite the amounts not being material to Altron’s financial position. Over the past three years, we have been steadfast in building a culture of good governance driven by our values of openness, honesty and integrity. Our employees are now able to come forward with any claims of misconduct without any fear of retaliation,” said Altron Group CE Mteto Nyati.

He added: “We are following due process and the three executives may go through a disciplinary hearing, overseen by an independent chairman. While the investigation is on-going, we would like to assure our customers, partners and employees that plans have been put in place to ensure business continuity at Altron Nexus,” Nyati concluded.

Stay in the loop! Leave your email for exclusive updates and content.